North America
The company is also gradually diversifying its business, with 20% of the expected value of new contracts coming from the non-diabetes business.
The Series C round brings the company's total raise to nearly $52 million.
Despite some wins across its various business efforts, Fitbit's mounting losses provide some insight as to why the company was looking to sell.
While medical education has felt stagnant since the 20th century, a new group of startups wants to make it more efficient, effective and affordable.
The acquisition also gives American Well access to a handful of major provider and payer customers.
The Boston-based company has now raised a hair over $90 million for its AI pathology platform.
Veterans will have secure access to a portable aggregated record of their allergies, immunizations, lab results, procedures and other health measures.
Also: Apple makes another cardiology hire; Blink Health brings on legal counsel.
The round included Founders Fund, Mayfield, DCM, Version One, Y Combinator and Liquid 2 Ventures.
This is the seventh FDA clearance for the longstanding mobile diabetes management platform.